Free Trial

Niagen Bioscience (NAGE) SEC Filings & 10K Form

Niagen Bioscience logo
$9.82 +0.05 (+0.51%)
As of 04:00 PM Eastern

Recent Niagen Bioscience SEC Filings

DateFilerForm TypeView
07/03/2025
9:42 AM
Niagen Bioscience (Issuer)
Shahbazi Hamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
4:29 PM
Niagen Bioscience (Issuer)
Patrick Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
4:30 PM
Niagen Bioscience (Issuer)
YU Wing Tak Wendy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
7:29 PM
Niagen Bioscience (Issuer)
Rubin Steven D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
7:23 PM
Jaksch Frank L Jr (Reporting)
Niagen Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
7:25 PM
Cohen Ann (Reporting)
Niagen Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
7:28 PM
Ng Wang Yu Gary (Reporting)
Niagen Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
6:52 PM
Fried Robert N (Reporting)
Niagen Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:32 AM
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:11 AM
Niagen Bioscience (Issuer)
Lopez Carlos Luis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:17 PM
Niagen Bioscience (Issuer)
Fried Robert N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:18 PM
Niagen Bioscience (Issuer)
Pamir Ozan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:19 PM
Niagen Bioscience (Issuer)
Lopez Carlos Luis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
6:12 PM
Niagen Bioscience (Issuer)
Jaksch Frank L Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
12:54 PM
Niagen Bioscience (Subject)
Jaksch Frank L Jr (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
6:28 AM
Niagen Bioscience (Issuer)
Pamir Ozan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
4:20 PM
Niagen Bioscience (Filer)
Form 424B3
11/21/2024
3:01 PM
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:47 PM
Niagen Bioscience (Issuer)
Lopez Carlos Luis (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/31/2024
3:00 PM
Niagen Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
3:01 PM
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:32 AM
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NAGE) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners